AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. INTS
  4. [8-K] Intensity Therapeutics, Inc. Common stock Reports Material Event

[8-K] Intensity Therapeutics, Inc. Common stock Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock INTS logo
INTENSITY THERAPEUTICS INC

NASDAQ:INTS

INTS Rankings

#10327 Ranked by Market Cap
N/A Ranked by Dividends

INTS Latest News

Aug 7, 2025
Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Aug 4, 2025
Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025
Jun 30, 2025
Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST)
Jun 11, 2025
Intensity Therapeutics, Inc. Announces Pricing of Public Offering
Jun 11, 2025
Intensity Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

INTS Latest SEC Filings

Aug 7, 2025
[8-K] Intensity Therapeutics, Inc. Common stock Reports Material Event
Aug 7, 2025
[10-Q] Intensity Therapeutics, Inc. Common stock Quarterly Earnings Report
Aug 4, 2025
[8-K] Intensity Therapeutics, Inc. Common stock Reports Material Event
Jul 9, 2025
[SCHEDULE 13G/A] Intensity Therapeutics, Inc. Common stock SEC Filing
Jul 2, 2025
[Form 4] Intensity Therapeutics, Inc. Common stock Insider Trading Activity

INTS Stock Data

7.64M
19.84M
23.91%
10.08%
1.49%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SHELTON